Website
News25/Ratings0
Latest news
25 items- INSIDERSEC Form 4: Mazzo David J covered exercise/tax liability with 397 shares, decreasing direct ownership by 0.41% to 96,543 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Mazzo David J covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 1% to 96,940 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Ruoslahti Erkki was granted 20,000 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Klosk Steven M was granted 20,000 shares, increasing direct ownership by 198% to 30,090 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Henson Heidi was granted 20,000 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Flowers Cynthia Louise was granted 20,000 shares, increasing direct ownership by 206% to 29,721 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Brown Gregory B was granted 20,000 shares, increasing direct ownership by 201% to 29,934 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Azab Mohammad was granted 20,000 shares, increasing direct ownership by 104% to 39,200 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Slack David W. was granted 24,000 shares and covered exercise/tax liability with 3,358 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Mazzo David J was granted 60,000 shares and covered exercise/tax liability with 11,315 shares, increasing direct ownership by 99% to 97,970 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Buck Kristen K was granted 18,000 shares and covered exercise/tax liability with 2,659 shares, increasing direct ownership by 75% to 35,823 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SECSEC Form 10-Q filed by Caladrius Biosciences Inc.10-Q - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECSEC Form S-8 filed by Caladrius Biosciences Inc.S-8 - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)8-K/A - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)8-K/A - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Other Events8-K - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECSEC Form 424B5 filed by Caladrius Biosciences Inc.424B5 - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - LISATA THERAPEUTICS, INC. (0000320017) (Filer)
- INSIDERSEC Form 3 filed by new insider Slack David W.3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 3: New insider Ruoslahti Erkki claimed ownership of 1,171,144 shares3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 3 filed by new insider Henson Heidi3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 4: Azab Mohammad was granted 19,200 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- INSIDERSEC Form 3 filed by new insider Azab Mohammad3 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SECCaladrius Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CALADRIUS BIOSCIENCES, INC. (0000320017) (Filer)